Henry Schein, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 24, 2022
November 01, 2022 at 02:08 pm EDT
Share
Henry Schein, Inc. reported earnings results for the third quarter and nine months ended September 24, 2022. For the third quarter, the company reported sales was USD 3,067 million compared to USD 3,178 million a year ago. Net income was USD 150 million compared to USD 162 million a year ago. Basic earnings per share from continuing operations was USD 1.1 compared to USD 1.16 a year ago. Diluted earnings per share from continuing operations was USD 1.09 compared to USD 1.15 a year ago.
For the nine months, sales was USD 9,276 million compared to USD 9,070 million a year ago. Net income was USD 491 million compared to USD 484 million a year ago. Basic earnings per share from continuing operations was USD 3.59 compared to USD 3.44 a year ago. Diluted earnings per share from continuing operations was USD 3.55 compared to USD 3.4 a year ago.
Henry Schein, Inc. specializes in the distribution of care products and services intended for health professionals (doctors, surgeons, dentists, veterinary laboratories and clinics). Net sales break down by activity as follows:
- distribution of health care products and equipment (94.3%): dental products and equipment (62.7% of net sales; consumable products, laboratory equipment, print materials, implants, anesthetics, etc.) and medical equipment (37.3%; medicines, vaccines, vitamins, surgical material, diagnostic tests, etc.);
- other (5.7%): sale and integration of management software, financial, training, maintenance and equipment repair services.
The United States account for 76.2% of net sales.
HENRY SCHEIN, INC. 
